Clinical Trial Update: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating localized radiation therapy or recombinant interferon beta with or without cellular adoptive immunotherapy in metastatic Merkel cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma
• Merkel Cell Polyomavirus Infection

Drugs mentioned

• Avelumab (avelumab)
• local radiation therapy
• recombinant interferon beta (interferon beta)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-03-22